Effects of bacterial vaginosis and its treatment on sexual functions: A cross-sectional questionnaire study

Year 2019, , 99 - 102, 01.08.2019

Coşkun Şimşir , Bora Coşkun , Buğra Coşkun , Aynur Adeviye Erşahin Tolga Ecemiş

https://doi.org/10.25000/acem.585436

Cited By: 2

Abstract

Aim: To investigate the effects
of bacterial vaginosis, which is the most frequent vaginal infection in women,
and its treatment on sexual functions.

Methods: Patients who had applied to our gynecology outpatient clinic
with bacterial vaginosis based on the culture results were included in this
observational questionnaire study. Patients with an accompanying disease
possibly resulting in sexual dysfunction and those with vaginitis etiology
other than bacterial vaginosis were excluded from the study. Patients were
asked to fill the Female Sexual Function Index (FSFI) during the diagnosis of
bacterial vaginosis and 1 month later than the treatment.

Results: Seventy-two patients who had applied to our outpatient clinic
between January 2018 and January 2019 and who met the study criteria were included
in this study. Statistically significant improvement was found in
post-treatment orgasm and pain scores and in total FSFI scores of the patients
upon comparison of FSFI scores of patients before and after the treatment (p<0.001).
However, no statistically significant differences were found in sexual desire,
arousal, lubricity and general satisfaction scores before and after the
treatment (p>0.05 for all).

Conclusion: It was
found that sexual dysfunction was more common in patients with bacterial vaginosis
and improvement was seen in some sexual functions with treatment.

Keywords

Bacterial vaginosis, sexual disfunction, Female Sexual Function Index

Bakteriyel vajinoz ve tedavisinin cinsel fonksiyonlar üzerine etkileri: Bir kesitsel anket çalışması

Abstract

Amaç: Kadınlarda en sık görülen vajinal enfeksiyon olan bakteriyel
vajinozun ve tedavisinin cinsel fonksiyonlara olan etkilerini araştırmak.

Yöntemler: Ocak 2018-Ocak 2019 tarihleri arasında jinekoloji
polikliniğimizde kültür sonuçlarına dayanarak bakteri vajinoz tanısı alan
hastalar bu gözlemsel anket çalışmasına dahil edildi. Eşlik eden bir hastalığı
olan ve muhtemelen cinsel işlev bozukluğu olan hastalar ile bakteriyel vajinoz
dışındaki vajinit etiyolojisi olanlar çalışma dışı bırakıldı. Hastalara bakteri
vajinoz teşhisi sırasında ve tedaviden 1 ay sonra Kadın Cinsel İşlev İndeksi (FSFI)
anketi uygulandı.

Bulgular: Çalışma kriterlerini karşılayan 75 hasta çalışmaya dahil
edildi. FSFI skorlarının karşılaştırılmasında tedavi sonrası orgasm, ağrı
skorları ve toplam FSFI skorlarında istatistiksel olarak anlamlı düzelme
saptandı (p<0,001). Ancak, tedavi öncesi ve sonrasında cinsel istek,
uyarılma, kayganlık ve genel memnuniyet skorlarında istatistiksel olarak
anlamlı bir fark bulunmadı (hepsi için p>0,05).

Sonuç: Bakteriyel vajinozlu hastalarda cinsel işlev bozukluğunun daha
yaygın olduğu ve tedaviyle bazı cinsel işlevlerde düzelme olduğu tespit edildi.

Keywords

Bakteriyel vajinoz, cinsel işlev bozukluğu, Kadın Cinsel İşlev İndeksi

References

• 1. Verstraelen H, Swidsinski A. The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment. Current Opinion Infectious Diseases. 2013;26:86-9.
• 2. Li M, Li L, Wang R, Yan SM, Ma XY, Jiang S, et al. Prevalence and risk factors for bacterial vaginosis and cervicitis among 511 female workers attending gynecological examination in Changchun, China. Taiwan J Obstet Gynecol. 2019;58:385-9.
• 3. AlAwlaqi A, Amor H, Hammadeh ME. Role of hormones in hypoactive sexual desire disorder and current treatment. J Turk Ger Gynecol Assoc. 2017;18:210-8.
• 4. Salonia A, Munarriz RM, Naspro R, Nappi RE, Briganti A, Chionna R et al. Women's sexual dysfunction: a pathophysiological review. BJU Int. 2004;93:1156-64.
• 5. Clayton AH, Valladares Juarez EM. Female Sexual Dysfunction. Med Clin North Am. 2019;103:681-98.
• 6. Pauls RN, Kleeman SD, Karram MM. Female sexual dysfunction: principles of diagnosis and therapy. ObstetGynecolSurv. 2005;60:196-205.
• 7. Krleža-Jerić K, Lemmens T. 7th Revision of the Declaration of Helsinki: Good News for the Transparency of Clinical Trials. Croat Med J. 2009;50:105-10.
• 8. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26:191-208.
• 9. Aygin D, Eti Aslan F. The Turkish Adaptation of The Female Sexual Function Index, Turkey Clinics J Med. 2005;25:393-9.
• 10. da Costa CKL, Spyrides MHC, de Sousa MBC. Consistency of three different questionnaires for evaluating sexual function in healthy young women. BMC Womens Health. 2018;18:204.
• 11. Thakar R. Review of current status of female sexual dysfunction evaluation in urogynecology. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20 Suppl 1:S27-31.
• 12. McCool ME, Theurich MA, Apfelbacher C. Prevalence and predictors of female sexual dysfunction: a protocol for a systematic review. Syst Rev. 2014;3:75.
• 13. Kingsberg S, Althof SE. Evaluation and treatment of female sexual disorders. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20 Suppl 1:S33-43.
• 14. Cayan S, Akbay E, Bozlu M, Canpolat B, Acar D, Ulusoy E. The prevalence of female sexual dysfunction and potential risk factors that may impair sexual function in Turkish women. Urol Int. 2004;72:52-7.
• 15. Oksuz E, Malhan S. Prevalence and risk factors for female sexual dysfunction in Turkish women. J Urol. 2006;175:654-8.
• 16. Bilardi JE, Walker S, Temple-Smith M, McNair R, Mooney-Somers J, Bellhouse C, et al. The burden of bacterial vaginosis: women's experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis. PLoS One. 2013;8:e74378.
• 17. Frølund M, Falk L, Ahrens P, Jensen JS. Detection of ureaplasmas and bacterial vaginosis associated bacteria and their association with non-gonococcal urethritis in men. PLoS One. 2019;14:e0214425.
• 18. Donders GGG, Bellen G, Ruban KS. Abnormal vaginal microbioma is associated with severity of localized provoked vulvodynia. Role of aerobic vaginitis and Candida in the pathogenesis of vulvodynia. Eur J Clin Microbiol Infect Dis. 2018;37:1679-85.
• 19. Levin RJ. The human sexual response-Similarities and differences in the anatomy and function of male and female genitalia. In: Janssen E, (Ed). The psychophysiology of sex. Bloomington: Indiana University Press; 2007. pp.35-56.
• 20. Lo SS, Kok WM. Prevalence and Risk Factors for Sexual Problems and Distress in Chinese Unmarried Young Women: An Observational Study. J Sex Med. 2018;15:1620-8.